Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-04-24

FDA Approved: THYROGEN — Supplemental Application (Genzyme Corporation)

View source ↗

Summary

FDA approved a supplemental application for THYROGEN (thyrotropin alfa) submitted by Genzyme Corporation. The action updates the labeling to reflect its diagnos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Thyrogen (thyrotropin alfa)

Snippet

SUPPL AP for THYROGEN (THYROTROPIN ALFA)